Evidence map›Paper›PMID 38106912›Full record

ArticleInterface focus2023

Chamber-specific wall thickness features in human atrial fibrillation.

Jichao Zhao, James Kennelly, Aaqel Nalar, Anuradha Kulathilaka, Roshan Sharma, Jieyun Bai, Ning Li, Vadim V Fedorov

Open access · hybridAbstract read
In one paragraph

Article in Interface focus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jichao ZhaoAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.ORCID 0000-0003-3303-0401
James KennellyAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Aaqel NalarAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Anuradha KulathilakaAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Roshan SharmaAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Jieyun BaiAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Ning LiDepartment of Physiology and Cell Biology, Bob and Corrine Frick Center for Heart Failure and Arrhythmia, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Vadim V FedorovDepartment of Physiology and Cell Biology, Bob and Corrine Frick Center for Heart Failure and Arrhythmia, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
University of Auckland · NZThe Ohio State University Wexner Medical Center · US

Funding

Targeting the Arrhythmogenic Sources of Human Atrial FibrillationR01HL135109 · NHLBI · OHIO STATE UNIVERSITY · PI Vadim V Fedorov · 2017 to 2026
$6.0M
Integration of structure and signaling in cardiac pacemaker functionR01HL115580 · NHLBI · OHIO STATE UNIVERSITY · PI FEDOROV, VADIM V · 2013 to 2021
$4.2M
NHLBI NIH HHS R01 HL115580NHLBI NIH HHS R01 HL135109
6 · The paper itself

Abstract

Persistent atrial fibrillation (AF) is not effectively treated due to a lack of adequate tools for identifying patient-specific AF substrates. Recent studies revealed that in 30-50% of patients, persistent AF is maintained by localized drivers not only in the left atrium (LA) but also in the right atrium (RA). The chamber-specific atrial wall thickness (AWT) features underlying AF remain elusive, though the important role of AWT in AF is widely acknowledged. We aimed to provide direct evidence of the existence of distinguished RA and LA AWT features underlying AF drivers by analysing functionally and structurally mapped human hearts

Indexed as

atrial fibrillationatrial wall thicknesscardiac arrhythmogenesishuman atria

Identifiers

PMID38106912
PMCPMC10722209
OpenAlexW4389794735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.